Chen C, Noland K A, Kalu D N
Department of Physiology, University of Texas Health Science Center at San Antonio 78284-7756, USA.
Mech Ageing Dev. 1997 Dec 15;99(2):109-22. doi: 10.1016/s0047-6374(97)00094-8.
Age-related decline in intestinal calcium (Ca) absorption often occur in postmenopausal osteoporotic women. The impaired Ca absorption can be corrected by estrogen (E2) therapy. Growth hormone (GH) therapy has also been reported to increase intestinal absorption of calcium. Since 1,25-dyhydroxyvitamin D (1,25(OH)2D) is the primary regulator of calcium absorption, we explored whether the mechanisms by which E2 and GH enhance Ca absorption involves the vitamin D endocrine system. We measured serum 1,25(OH)2D concentrations and determined the binding characteristics of intestinal vitamin D receptors (VDRs) in four groups of female rats: sham operated (sham), ovariectomized (ovx), ovx + E2, and ovx + GH. Serum 1,25(OH)2D levels were 42.4 +/- 3.4 and 42.5 +/- 3.2 pg/ml in sham and ovx rats, respectively, and decreased by 63 and 34% (P < 0.001) in ovx + E2 and ovx + GH-treated rats, respectively. The numbers of total, unoccupied and occupied VDRs were 116.9 +/- 2.0, 72.1 +/- 1.1 and 44.8 +/- 1.9 fmol/mg protein, respectively, in sham operated rats, and decreased significantly following ovariectomy by 24, 27 and 19% (P < 0.01), respectively. E2 therapy not only significantly increased total, unoccupied and occupied VDRs above those of ovx rats by 55, 58 and 49% respectively, but it increased the levels above those of sham operated controls as well (P < 0.01). In contrast, GH administration prevented the decrease that occurred in ovx rats in the number of total and unoccupied VDRs (111.2 +/- 3.3; 72.6 +/- 1.4 fmol/mg protein, respectively), but it had no significant effect on the number of occupied VDRs. The dissociation constant (Kd) of intestinal VDRs was unaltered by ovariectomy, E2 and GH. We conclude that down regulation of intestinal VDRs may contribute to the Ca malabsorption that occurs in ovarian hormone deficient states such as postmenopausal osteoporosis, and that the stimulation of Ca absorption by E2 and GH may result, in part, from up regulation of intestinal VDRs.
绝经后骨质疏松女性常出现与年龄相关的肠道钙吸收下降。雌激素(E2)治疗可纠正受损的钙吸收。据报道,生长激素(GH)治疗也能增加肠道对钙的吸收。由于1,25 - 二羟维生素D(1,25(OH)2D)是钙吸收的主要调节因子,我们探讨了E2和GH增强钙吸收的机制是否涉及维生素D内分泌系统。我们测量了四组雌性大鼠的血清1,25(OH)2D浓度,并测定了肠道维生素D受体(VDR)的结合特性:假手术组(sham)、卵巢切除组(ovx)、ovx + E2组和ovx + GH组。假手术组和卵巢切除组大鼠的血清1,25(OH)2D水平分别为42.4±3.4和42.5±3.2 pg/ml,而在ovx + E2组和ovx + GH治疗组大鼠中分别下降了63%和34%(P < 0.001)。假手术组大鼠中,总VDR、未占据VDR和占据VDR的数量分别为116.9±2.0、72.1±1.1和44.8±1.9 fmol/mg蛋白,卵巢切除后分别显著下降24%、27%和19%(P < 0.01)。E2治疗不仅使总VDR、未占据VDR和占据VDR的数量分别比卵巢切除组大鼠显著增加55%、58%和49%,而且使其水平高于假手术对照组(P < 0.01)。相比之下,给予GH可防止卵巢切除组大鼠总VDR和未占据VDR数量的减少(分别为111.2±3.3;72.6±1.4 fmol/mg蛋白),但对占据VDR的数量无显著影响。肠道VDR的解离常数(Kd)不受卵巢切除、E2和GH的影响。我们得出结论,肠道VDR的下调可能导致绝经后骨质疏松等卵巢激素缺乏状态下发生的钙吸收不良,而E2和GH对钙吸收的刺激可能部分源于肠道VDR的上调。